ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s.
Hrusch CL, Manns ST, Bryazka D, Casaos J, Bonham CA, Jaffery MR, Blaine KM, Mills KAM, Verhoef PA, Adegunsoye AO, Williams JW, Tjota MY, Moore TV, Strek ME, Noth I, Sperling AI.
Hrusch CL, et al. Among authors: williams jw.
Mucosal Immunol. 2018 Jan;11(1):61-70. doi: 10.1038/mi.2017.42. Epub 2017 May 10.
Mucosal Immunol. 2018.
PMID: 28488693
Free PMC article.